重大公告
Contract Signing with Pharmacore for the Contract Manufacturing of OBI-858
Date of occurrence: September 25, 2017 Contract or the other party to the contract: PharmaCore Biotech Co., Ltd Relationship to the Company (please enter ”head …
Announcement on Change of the Acting Spokesperson
Type of personnel changed (please enter: spokesperson, acting spokesperson, important personnel(CEO, COO, CMO, CSO, etc.),financial officer, accounting officer, research and development officer, or internal audit …
Announcement on Change of the Head of Finance and Accounting
Type of personnel changed (please enter: spokesperson, acting spokesperson, important personnel(CEO, COO, CMO, CSO, etc.),financial officer, accounting officer, research and development officer, or internal audit …
OBI Received a Civil Complaint from Taiwan Shilin District Court
Parties to the legal matter: Plaintiff: Securities and Futures Investors Protection Center (SFIPC) Defendant: OBI Pharma, Inc. and Dr. Michael N. Chang (Chairman) Name of …
Clarification on the news article by China Times
Date of occurrence: July 12, 2017 Company name: OBI Pharma, Inc. Relationship to the Company (please enter ”head office” or ”affiliated company”): N/A Reciprocal shareholding …